SCIEX Expands BioPhase 8800 System Capabilities to Help Laboratories Accelerate Development and Decision-making for Emerging Therapeutics
🤖 D.R.A.F.T. Summary
SCIEX Expands BioPhase 8800 System Capabilities to Help Laboratories Accelerate Development and Decision-making for Emer
MARLBOROUGH, Mass. — SCIEX, a Danaher company and leader in life science analytical technologies, today announced new capillary electrophoresis (CE) capabilities for the BioPhase 8800 system that help laboratories accelerate development timelines, strengthen compliance, and integrate more seamlessly into automated workflows.
Outlets covering this story
Financial Post
CENTER
Only one perspective covered this story — no diversity detected
Side-by-Side Outlet Comparison — Starter+
See how 1 outlets framed this story — bias by source, F.A.C.T. framing analysis, and verdict side by side.
Unlock with Starter →